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Hepatoma upregulated protein (HURP) is a multifunctional protein with clinical prom-
ise. This protein has been demonstrated to be a predictive marker for the outcome 
in high-risk prostate cancer (PCa) patients, besides being a resistance factor in PCa. 
Although changes in oxygen tension (pO2) are associated with PCa aggressiveness, 
the role of hypoxia in the regulation of tumor progression genes such as HURP has not 
yet been described. We hypothesized that pO2 alteration is involved in the regulation of 
HURP expression in PCa cells. In the present study, PCa cells were incubated at 2% O2 
(hypoxia) and 20% O2 (normoxia) conditions. Hypoxia reduced cell growth rate of PCa 
cells, when compared to the growth rate of cells cultured under normoxia (p < 0.05). The 
decrease in cell viability was accompanied by fivefold (p < 0.05) elevated rate of vascular 
endothelial growth factor (VEGF) release. The expression of VEGF and the hypoxia-in-
ducible metabolic enzyme carbonic anhydrase 9 were elevated maximally nearly 61-fold 
and 200-fold, respectively (p < 0.05). Noted in two cell lines (LNCaP and C4-2B) and 
independent of the oxygen levels, HURP expression assessed at both mRNA and pro-
tein levels was reduced. However, the decrease was more pronounced in cells cultured 
under hypoxia (p < 0.05). Interestingly, the analysis of patients’ specimens by Western 
blot revealed a marked increase of HURP protein (fivefold), when compared to control 
(cystoprostatectomy) tissue (p  <  0.05). Immunohistochemistry analysis showed an 
increase in the immunostaining intensity of HURP and the hypoxia-sensitive molecules, 
hypoxia-inducible factor 1-alpha (HIF-1α), VEGF, and heat-shock protein 60 (HSP60) in 
association with tumor grade. The data also suggested a redistribution of subcellular 
localization for HURP and HIF-1α from the nucleus to the cytoplasmic compartment in 
relation to increasing tumor grade. Analysis of HURP Promoter for HIF-1-binding sites 
Abbreviations: CA9, carbonic anhydrase 9; CO2, carbon dioxide; DLGAP5, discs, large (Drosophila) homolog-associated pro-
tein 5; DNA, deoxyribonucleic acid; ELISA, enzyme-linked immunosorbent assay; HIF-1α, hypoxia-inducible factor 1-alpha; 
HIFs, hypoxia-inducible factors; HSP, heat-shock protein; HURP, hepatoma upregulated protein; IHC, immunohistochemistry; 
mRNA, messenger ribonucleic acid; O2, dioxygen; PCa, prostate cancer; pO2, oxygen tension; qRT-PCR, reverse transcription 
polymerase chain reaction; RNA, ribonucleic acid; VEGF, vascular endothelial growth factor.
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revealed presence of four putative HIF binding sites on the promoter of DLGAP5/HURP 
gene in the non-translated region upstream from the start codon, suggesting association 
between HIF-1α and the regulation of HURP protein. Taken together, our findings suggest 
a modulatory role of hypoxia on the expression of HURP. Additionally our results provide 
basis for utilization of tumor-associated molecules as predictors of aggressive PCa.
Keywords: hUrP, hypoxia, prostate cancer, lncaP, c4-2B, tumor
inTrODUcTiOn
Prostate cancer (PCa) remains the most common form of cancer 
affecting men in the Western Hemisphere. In 2015, an estimated 
220,800 new cases of PCa are expected to occur in the US and 
an estimated 27,540 deaths are expected nationwide (1). On the 
assessment of the aggressiveness of PCa, factors of tumor micro-
environment have received increasing attention. In particular, the 
role of oxygen tension [potentia oxygenii (pO2)] in tumor biol-
ogy is of special relevance. Unappreciated for a long time, tumor 
hypoxia has been recently linked to malignant progression, 
metastasis, resistance to therapy, and poor clinical outcomes, 
particularly in the case of PCa (2–4). Likewise, addition of 
hypoxia as a variable improved prognostic accuracy of aggressive 
PCa, when added to currently used clinicopathological variables 
(5). This demonstrates the relevance of hypoxia, a variable of the 
microenvironment, as a factor of aggressiveness in PCa.
We previously reported that a subset of transcripts of hypoxia-
associated genes are relevant as markers of PCa progression 
(6). One of these genes, namely hepatoma upregulated protein 
(HURP), was found to be associated with Gleason score and 
systemic progression of PCa, in addition to being a potential 
independent outcome predictor in high-risk PCa (6). Moreover, 
the induction of HURP expression in PCa cells was shown by us 
to inhibit γ-irradiation-induced apoptosis via destabilization of 
p53 and ATM, key proteins in the modulation of γ-irradiation-
induced apoptosis (7). Thus, in addition to its reliability as a 
prognostic biomarker in patients at high-risk of developing 
aggressive PCa, HURP seems to trigger PCa resistance to stand-
ard antitumor therapies.
It has been generally accepted that conditions of tumor 
microenvironment including hypoxia promote disease progres-
sion and metastasis via mechanisms mediated by chromosomal 
instability, gene amplification, and decreasing tumor sensitivity 
to DNA damaging agents (8, 9). The above mentioned tumor-
associated aberrations contribute to disease development and 
resistance to therapies (10–12). HURP expression is tightly 
regulated during cell cycle progression (13–15) and is a compo-
nent of the Ran-importin β-regulated spindle assembly pathway 
(16). HURP possesses significant regions of positive charge that 
are postulated to interact with microtubules (17), suggesting 
an essential role for this protein on the regulation of cell cycle 
control. Accordingly, the overexpression of HURP in 293T 
cells and NIH3T3 embryonic fibroblasts at low serum levels 
was associated with the promotion of cell growth and colony 
formation, respectively (14, 18, 19). In contrast, the knockdown 
of HURP in SK-Hep-1-derived hepatoma model delayed tumor 
formation (19).
When analyzed in total, the available information utilizing 
in vitro and in vivo models suggest that HURP’s biological prop-
erties are compatible with its role in carcinogenesis. Changes in 
pO2 contribute to the aggressiveness of tumors as well, but it is 
less clear whether hypoxia affects HURP expression. The present 
study provides the first insight into the biological properties of 
HURP as a hypoxia-associated gene in tumor development and 
progression.
MaTerials anD MeThODs
cell culture
The human PCa cell lines LNCaP and C4-2B were obtained from 
the Characterized Cell Line Core Facility, University of Texas MD 
Anderson Cancer Center. C4-2B cells represent a human bone 
metastatic PCa and were derived from LNCaP cells. They have 
more aggressive characteristics when compared to their parental 
cells (20). For methylation experiments, we utilized LNCaP, 
DU-145, and PC3 PCa cell lines purchased from the ATCC. Cells 
were cultured as recommended by the company. All utilized cell 
lines were genotyped by STR DNA fingerprinting. They were 
mycoplasma-free following the detection with the MycoAlert™ 
Mycoplasma Detection Kit (cat # LT07-218; Lonza, Allendale, NJ, 
USA). Cells were routinely cultured in phenol red RPMI-1640 
supplemented with 10% heat-inactivated fetal bovine serum 
(Cellgro, Manassas, VA, USA) at 37°C in humidified air enriched 
with 5% CO2 and with O2 content either 20% (normoxic) or 2% 
(hypoxic) in a CB-150 (Binder, Germany) CO2 incubator. The cells 
were trypsinized at 80–90% confluence and plated at the density 
of 12,000 cells/cm2. The medium was not refreshed during the 
course of the experiments. To evaluate cell viability, cells exclud-
ing trypan blue were counted by the aid of a hemocytometer.
Measurement of VegF concentration in 
conditioned Media
Concentrations of vascular endothelial growth factor (VEGF) 
in supernatants were measured by a commercial enzyme-
linked immunosorbent assay (ELISA) kit (R&D Systems, Inc., 
Minneapolis, MN, USA) according to the manufacturer’s instruc-
tions. This ELISA kit has been shown to recognize recombinant 
human VEGF165, recombinant human VEGF121, and recombinant 
human VEGF165b. The lower detection limit of the kit was 31.3 pg/
mL. Rate of VEGF secretion was expressed as pg/(mL/cell/day).
Quantitative rT-Pcr
Total mRNA was isolated using RNeasy Mini kit (Qiagen, 
Germantown, MD, USA) according to the manufacturer’s 
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instructions: 1-μg RNA was reversely transcribed using 
SuperScript III First Strand Synthesis (Invitrogen, Grand Island, 
NY, USA). Subsequently, quantitative PCR was performed with 
a LightCycler 480 SYBR Green I Master (Roche, Madison, WI, 
USA). Levels of mRNA were normalized relative to the levels 
of control ribosomal protein S28 (RPS28) mRNA (21). Data 
were analyzed by the Delta Delta Ct (2-ΔΔCT) method using 
Excel program. Primer sequences used were (forward/reverse): 
VEGF-α: 5′-AGT CCA ACA TCA CCA TGC AG-3′/5′-TTC 
CCT TTC CTC GAA CTG ATT T-3′, carbonic anhydrase 9 
(CA9): 5′-TTT GCC AGA GTT GAC GAG G-3′/5′-AGC CTT 
CCT CAG CGA TTT C-3′, HURP: 5′-CAT TTT CCT TCA TAT 
TAT CAA TG-3′/5′-CAT TAT ATG CTA TAG AAG TGA ACA 
C-3′, and ribosomal protein S28 (RPS28): 5′-TTT TGG AGT 
CAG AGC GAG AAG-3′/5′-AGC ATC TCA GTT ACG TGT 
GG-3′.
Preparation of Protein extracts
Cells were washed with cold phosphate-buffered saline (PBS) 
and lysed in RIPA buffer. Cells lysates were sonicated on ice 
for 2 min with 30 s intervals followed by vortexing every 5 min 
during 45 min at 4°C. Lysates were centrifuged at 24,000 × g for 
10 min. Supernatants were collected and saved at −80°C. For flash 
frozen tissue, prostate obtained from PCa patients (n = 8) and 
cystoprostatectomy patients (n = 4; used as control) was utilized. 
Cystoprostatectomy is a surgical procedure, which combines 
a cystectomy and a prostatectomy for the removal of bladder 
cancer tumors. Tissues were homogenized in an IKA Work tissue 
homogenizer (Wilmington, NC, USA). Proteins were extracted 
from the homogenate with the AllPrep DNA/RNA/Protein Mini 
Kit (Qiagen, Germantown, MD, USA) according to the manu-
facturer’s guidelines. Protein concentration was determined by 
Bradford assay (Bio-Rad, Hercules, CA, USA) using bovine 
γ-globulin (Pierce, Rockford, IL, USA) as standard.
sDs-Page and Western Blot analysis
Fifty micrograms of protein were separated in a 10.5–14% SDS-
PAGE gradient gel, transferred to a nitrocellulose membrane, and 
incubated with blocking buffer containing primary antibodies 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) specific for 
HURP (diluted 1/400; sc-68540), β-actin (1/5000; Sc-8432), and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 1/5000; 
Sc-25778). The anti hypoxia-inducible factor 1-alpha [HIF-1α 
antibody (1/500)] was from R&D Systems (AF1935). Bound pri-
mary antibodies were visualized with HRP-conjugated antibodies 
specific for human IgG (diluted 1/1000 in blocking buffer; Abcam, 
Cambridge, MA, USA). After addition of a chemiluminescent sub-
strate (Rockford, IL, USA), the membrane was immediately exposed 
on a CL-XPosure film (Thermo Fisher Scientific) and scanned with 
an Epson Perfection 4490 Photo scanner to detect bands. Relative 
intensities of the bands were quantified using ImageJ software (NIH 
online, Bethesda, MD, USA); the recorded values were normalized 
to the intensity of the respective β-actin signal.
immunohistochemistry
According to the manufacturer’s instruction provided in 
ABC Kit (Vector Laboratories Inc., Burlingame, CA, USA), 
immunohistochemistry (IHC) was performed on formalin fixed 
and paraffin embedded samples of benign prostatic tissues, low 
grade PCa, and high grade PCa. Briefly, 5-μm sections in thick-
ness were deparaffinized and rehydrated followed by antigen 
retrieval with citrate buffer (pH 6.0) for 20 min. Endogenous 
peroxidase activity was quenched with 3% hydrogen peroxide 
for 10  min and unspecific bindings were blocked with 10% 
normal serum in room temperature for 1 h. Next, the slides were 
incubated with primary antibodies against HURP [rabbit poly-
clonal diluted 1/100 (cat # ab84509; Santa Cruz Biotechnology, 
Inc., Dallas, TX, USA)]; hypoxia-inducible factor 1-alpha 
(HIF-1α) [H-206, rabbit polyclonal diluted 1/50 (cat # sc-10790; 
Santa Cruz Biotechnology)]; heat-shock protein 60 (HSP60) 
[mouse monoclonal (LK1) diluted 1/50 (Abcam, Cambridge, 
MA, USA)]; and VEGF [VEGF (147), rabbit polyclonal diluted 
1/50 (cat # sc-507; Santa Cruz Biotechnology)]. Sections were 
incubated overnight at 4°C. Negative controls were prepared 
by using a normal anti-rabbit IgG. After PBS wash, the slides 
were incubated with the components in ABC kits, and with 
3,3 ′-diaminobenzidine (DAB) for color development. Finally, 
slides were counterstained in hematoxylin and mounted. Under 
microscope, subcellular localizations of IHC signals for each 
antibody were defined as membranous, cytoplasmic, or nuclear 
stain. The stain intensity was graded as no stain, weak, moder-
ate, and strong.
Methylation assay
DNA (500  ng) from log growing LNCaP, DU-145, and PC3 
cell lines was treated with sodium bisulfite and later purified 
using the EZ DNA Methylation Kit from Zymo Research (San 
Diego, CA, USA), as recommended. The bisulfite-treated DNA 
(BST-DNA) was denatured with 0.1  N NaOH for 10  min at 
room temperature and then amplified at 37°C for 24 h follow-
ing Illumina’s recommended protocols, as we have previously 
published (22). The amplified DNA sample was then fragmented 
at 37°C for 1 h and precipitated with 2-propanol by centrifugation 
at 3000 ×  g for 20  min at 4°C. The DNA pellet was air dried, 
resuspended in buffer, and hybridized for 24  h at 48°C to the 
Illumina chips HumanMethylation27 to interrogate 27,000 CpG 
in more than 14,000 genes. A single-base extension protocol is 
followed by staining of the beadchip and several washing steps, 
as recommended by the manufacturer (Illumina). The chips 
were dried under vacuum for 55  min and scanned using the 
BeadArray reader (Illumina). The beta fraction (β value) of the 
HURP gene was obtained utilizing the GenomeStudio software 
v2011.1. For methylation analysis of HURP, we focused on cg 
25465634-4010161.
Bioinformatics analysis for hUrP 
Promoter
The promoter region of DLGAP5/HURP was studied for the bind-
ing sites of the transcription factor HIF using reported evidence 
(23, 24) on the minimal cis-regulatory elements required for HIF-
dependent transactivation. Identified potential binding sites were 
analyzed in context of their location in methylated DNA regions. 
FigUre 2 | effect of hypoxia on VegF production: rates of vascular 
endothelial growth factor (VegF) release in conditioned culture media 
were measured by elisa for c4-2B cells growing under hypoxia (■) 
or normoxia (□). *p < 0.05 when data at 2% O2 are compared to values at 
20% O2 at the same time point; #p < 0.05 when data at 2% O2 or 20% O2 are 
compared to a previous time point within the same O2%; and &p < 0.05 when 
a specific data point is compared to the point at day 0 within the same O2%.
FigUre 1 | effect of hypoxia on cell viability: c4-2B cells were 
cultured at under hypoxia (■) or normoxia (□). Alive cells were counted 
in triplicate flasks using trypan blue exclusion to differentiate dead cells. 
*p < 0.05 when data at 2% O2 are compared to values at 20% O2 at the 
same time point; #p < 0.05 when data at 2% O2 or 20% O2 are compared to 
a previous time point within the same O2%; and &p < 0.05 when a specific 
data point is compared to the point at day 0 within the same O2%.
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The possible binding sites were defined by those having at least 
80% of nucleotide content identical to the reported canonical 
binding site for HIF (23, 24).
statistics
All reported values represent three independent cell culture 
experiments expressed as means ± SEM. Data for cell numbers, 
VEGF release, and mRNA expression were analyzed by two-way 
ANOVA (pO2 vs. day), followed by a post hoc Student–Newman–
Keuls multiple comparisons test. Difference in HURP protein 
between tumor and normal tissue lysates were analyzed by the 
Mann–Whitney U test. A difference was considered significant 
at p < 0.05.
resUlTs
sensitivity to hypoxia
We first evaluated the effect of hypoxia on cell viability in 
C4-2B cells exposed to 20% O2 (normoxia) or 2% O2 (hypoxia). 
Accordingly, the number of living cells was counted in a time 
course experiment. Under normoxia (Figure  1), a significant 
increase of cell numbers was noted on day 2 (p <  0.05), and 
increased thereafter to reach a maximum on day 8, while under 
hypoxia, the increased cell numbers were markedly higher (three-
fold), when compared to the cell numbers on day 0 (p < 0.05). 
Numbers remained unchanged until day 6, and slightly increased 
by 20% at day 8. Cell numbers under normoxia, in contrast, did 
not experience further variation until completion of the experi-
ment at day 8. Taken together, these findings show that C4-2B 
cells cultured under hypoxia have a significantly reduced growth 
kinetics relative to those cultured under normoxia.
Rate of release of VEGF and the hypoxia-inducible 
 pro-angiogenic factor associated with growth and aggressiveness 
(25) was next evaluated in cell culture supernatants by ELISA. As 
shown in Figure 2, under normoxia, the rate of released VEGF 
to the conditioned media was constant (2.5 pg/cell/day) up to day 
8 (≈2.5 pg/cell/day). Cells cultured under hypoxia had constant 
induction until day 6. At that time point, a maximum release rate 
at day 6 (12.3 pg/cell/day) was noted. The release rate of VEGF 
decreased thereafter (p < 0.05) on day 8. At that last time point a 
release rate of 8.3 pg/cell/day was observed. The results indicate 
that exposure of C4-2B cells to low levels of oxygen enhances the 
production of the angiogenic factor, VEGF.
We next assessed whether transcriptional regulation of 
VEGF was associated with its production in cells cultured under 
hypoxia. Cells were incubated under normoxia or hypoxia over 
a period of 8  days, mRNA was extracted, and qRT-PCR was 
performed. The induction of VEGF expression (61-fold) was 
noted first on day 4 (p < 0.05) in cells growing under hypoxia, 
when compared with control cells (Figure 3A). In cells growing 
under normoxia, induction of VEGF transcripts was noted as 
well (p < 0.05). Particularly, on day 8, a 10-fold induction was 
evidenced. Observed levels in cells under normoxia at that time 
point were comparable to those noted in cells growing at 2% O2 
(15.9-fold over base line).
Similar to VEGF, hypoxia-inducible metabolic enzyme CA9 
is overexpressed in cancer cells (26) and has been proposed as a 
useful marker for hypoxic exposure (27). When measured, the 
transcripts of CA9 had a sustained induction over the 8 days of 
exposure to low oxygen (Figure 3B). On day 8, nearly 200-fold 
induction over baseline on day 0 was observed in hypoxic C4-2B 
cells (p < 0.05). In cells cultured under normoxia, no expression 
of CA9 was noted for most of the analyzed time course, but for 
FigUre 3 | assessment transcripts of hypoxia-responsive genes: 
mrna levels of; (a) Vascular endothelial growth factor (VegF) and; (B) 
carbonic anhydrase 9 (ca9) were analyzed in c4-2B cells growing 
under hypoxia (■) or normoxia (□). *p < 0.05 when data at 2% O2 are 
compared to values at 20% O2 at the same time point; #p < 0.05 when data 
at 2% O2 or 20% O2 are compared to a previous time point within the same 
O2%; and &p < 0.05 when a specific data point is compared to the point at 
day 0 within the same O2%.
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11.4-fold induction over basal levels, observed at day 6 (p < 0.05). 
In consistency with our recent publication (28) and reports from 
others (29, 30), our findings show that PCa cells exhibit features of 
increased aggressiveness when they are cultured under hypoxia.
effects of Oxygen Tension on the 
expression of hUrP
We previously reported on the value of hypoxia-associated genes 
as prognostic markers of aggressive PCa (6). Among identified 
genes, transcripts of HURP independently predicted outcome in 
high-risk PCa (6). Because the role of hypoxia in the regulation 
of HURP expression is poorly understood, we set out to inves-
tigate the effect of varying oxygen levels on its expression. We 
assessed protein levels by Western blot analysis (Figures 4A,B) 
in C4-2B cells and their precursor cells, the LNCaP cell line 
(20). HURP protein levels were relatively low in LNCaP cells, 
compared to those detected in C4-2B at day 0. When quantified 
(Figures 4C,D), HURP protein increased to a similar extent at 
day 2 in LNCaP cells under normoxia (7.7-fold) and hypoxia (6.8-
fold). In C4-2B cells, the increase was more pronounced in cells 
cultured under normoxia (1.6-fold) relative to those cultured at 
2% O2 (1.2-fold). Irrespective of cell line and oxygen levels, HURP 
protein was drastically reduced over time. Under normoxia, the 
reduction of HURP expression was first noted at culture day 4 (21 
and 61% decrease for LNCaP and C4-2B cells, respectively) and 
was reduced thereafter close to 90% over maximum induction, 
regardless of the cell line, on day 8. Under hypoxic conditions the 
reduction of HURP protein was more pronounced. This observa-
tion was particularly evident in the case of C4-2B cells; HURP 
protein was reduced by 93% on day 4 and was undetectable at 
days 6 and 8 in this cell line.
We next studied the expression level of HIF-1α protein 
(Figures 4A,B), a key regulator of cellular responses to variation 
in pO2. Expression level of HIF-1α quantified on day 2 (Figure 4E) 
was increased in LNCaP cultured under normoxia (3-fold) and 
hypoxia (1.8-fold). At that time point, HIF-1α protein was reduced 
(Figure 4F) by 10% in normoxia and 20% in hypoxia in C4-2B 
cells. From day 4, HIF-1α protein was considerably reduced under 
normoxic condition. In C4-2B cells, however, a more pronounced 
decrease (68% reduction at day 8), relative to that observed in 
LNCaP cells (55% reduction at day 8) was noted when the 
maximum level of HIF-1α for each corresponding condition was 
used as reference. The expression of HIF-1α was differentially 
affected by hypoxia in LNCaP and C4-2B cells. Following maxi-
mal expression at day 2 (1.8-fold), levels of expression of HIF-1α 
remained unchanged until day 8. C4-2B cells growing in hypoxia 
had 50% reduction in HIF-1α protein from base level after 4 days 
of culture; however, the decrease was not as pronounced as that 
observed in cells growing in normoxia. Under low oxygen level, 
HIF-1α protein levels remained unchanged (42% of base level) 
until culture day 8.
Next, we studied the transcriptional regulation of HURP 
under hypoxia using qRT-PCR analysis. In LNCaP cells, induc-
tion of HURP transcripts on day 2 (1.3-fold, p < 0.05) was evident 
for cells cultured under normoxic condition (Figure 5A). At that 
time point, cells growing under hypoxia had a 65% decrease in 
HURP transcripts (p < 0.05). From day 4 and thereafter, a pro-
nounced reduction in HURP transcripts was noted irrespective 
of pO2 in LNCaP cells. Accordingly, at day 8, a decline of 98 and 
94% over maximum levels was noted for cells growing under 
normoxia and hypoxia, respectively (p <  0.05). In accordance 
with protein expression data in C4-2B cells, early induction of 
mRNAs for HURP (Figure 5B) was noted on day 2. The increase 
in HURP transcripts observed at 20% O2 (3-fold, p < 0.05), was 
more pronounced than that noted in cells growing at 2% O2 (1.2-
fold, n.s.). In C4-2B cells growing under normoxia, a reduction to 
baseline level was noted on day 4 (p < 0.05). At this oxygen level, 
additional decline in HURP transcripts was noted as function of 
time (p < 0.05), 68% on day 6 and 95% decrease on day 8. Under 
hypoxia, HURP transcripts increased by 27% on day 2 (p < 0.05), 
relative to the levels on day 0. Moreover, a time-dependent reduc-
tion of HURP expression was noted on day 4 (~70%), on day 6 
(~70%), and on day 8 (85%). These findings suggest that HURP 
expression is associated to adaptive mechanisms of cellular 
response to varying oxygen tension.
FigUre 4 | assessment transcripts of hypoxia-responsive genes: prostate cancer cells were cultured under hypoxia or normoxia during the 
indicated time intervals. Protein lysates were prepared and 50 μg of the total protein was fractionated on the 12% SDS-PAGE, blotted onto the nitrocellulose 
membrane, and tested against antibodies. Western blot analysis using anti-hepatoma upregulated protein (HURP), hypoxia-inducible factor 1-alpha (HIF-1α), and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibodies in (a) LNCaP cells and (B) C4-2B cells. The relative intensities of the bands under hypoxia (■) or 
normoxia (□) were quantified using the ImageJ software, and all the values were normalized to the intensities of the respective GAPDH signal. Data are expressed 
as the fold change obtained after dividing the optical density of HURP (c,D); and HIF-1α (e,F) proteins for a given cell line and time point, relative to the OD 
observed of the respective protein under the corresponding value at 0 days.
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levels of hUrP Protein in Pca Tissues
Based on our publication regarding the prognostic value of 
HURP in aggressive PCa (6), we next explored the expression 
of HURP protein in PCa tumors. For this purpose, we prepared 
protein lysates from PCa tumors obtained from patients selected 
over the basis of their HURP mRNA expression and analyzed 
them by Western blot. Prostatic tissue was obtained from patients 
suffering with PCa or cystoprostatectomy (controls). Separated 
proteins were transferred onto a nitrocellulose membrane and 
blotted against anti-human HURP antibodies. The level of HURP 
protein (Figure 6A) was analyzed by Western blot. Densitometry 
analysis revealed almost fivefold higher relative in PCa tissue rela-
tive to control (cystoprostatectomy) tissue (p < 0.05) (Figure 6B). 
These data suggest that protein expression for HURP can be 
elevated in PCa tumors at the protein level.
histological localization of hUrP in the 
context of hypoxia-responsive Molecules
We next performed IHC in FFPE tissue blocks obtained from 
benign, low grade, and high grade PCa, as shown in Figure 7A 
(low magnification, 10×) and 7B (high magnification, 40×). IHC 
signals for HURP were moderate in nuclei staining and weak in 
cytoplasm localization of both benign prostatic epithelia and low 
grade PCa. High staining was found in the nuclei and cytoplasm 
of high grade PCa. Since expression of hypoxia-regulated mol-
ecules has been found associated with pathology and aggressive 
phenotype in PCa (3, 29, 31), we next evaluated their histological 
localization in relation with tumor grade. Similarly to HURP, IHC 
signals for HIF-1α were moderate in nuclei, and weak in cytoplasm 
of benign prostatic epithelia, moderate in both cytoplasm and 
nuclei of low grade PCa, and strong in both nuclei and plasma of 
high grade PCa. The immune intensity of VEGF, a HIF-1α induced 
protein, was also analyzed. IHC signals for VEGF were strong in 
nuclei and moderate in cytoplasm of benign prostatic epithelia, 
moderated in both nuclei and cytoplasm of low grade PCa, and 
strong in both nuclei and cytoplasm of high grade PCa. Finally, 
histological expression of HSP60, the mitochondrial chaperonin, 
actively involved in the accumulation of HIF-1α (32) was also 
analyzed. The pattern of IHC signals for HSP60 was different to 
FigUre 5 | effect of hypoxia on hUrP mrna: mrna levels of 
hepatoma upregulated protein (hUrP) were analyzed in lncaP (a) 
and c4-2B (B) cells growing under hypoxia (■) or normoxia (□) during 
8 days. *p < 0.05 when data at 2% O2 are compared to values at 20% O2 at 
the same time point; #p < 0.05 when data at 2% O2 or 20% O2 are compared 
to a previous time point within the same O2%; and &p < 0.05 when a specific 
data point is compared to the point at day 0 within the same O2%.
FigUre 6 | expression of hUrP protein in Pca tissues. Protein lysates (50 μg) extracted from frozen prostate tissues (C1–C4 samples from cytoprostatectomy 
patients and P1–P8 samples from PCa patients) were separated by SDS-PAGE. (a) Hepatoma upregulated protein (HURP) and beta (β)-actin levels in the samples 
were identified by Western blot as described in Section “Materials and Methods.” (B) The results were normalized to β-actin. Normalized ratios were compared 
between controls and PCa tumors. The level of significance was set at p < 0.05 between PCa and cytoprostatectomy samples.
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FigUre 7 | continued
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FigUre 7 | histopathology of hUrP and hypoxia-sensitive molecules in association with prostate cancer progression. Hepatoma upregulated 
protein (HURP), hypoxia-inducible factor 1-alpha (HIF-1α), Vascular endothelial growth factor (VEGF), and Heat-shock protein 60 (HSP60) immunostaining was 
assessed in benign tissues, Gleason <7 low grade PCa, and Gleason >7 high grade PCa tumors. Slides were counterstained in hematoxylin and mounted. 
Representative images of HURP, HIF-1α, VEGF, and HSP60 expression in bening tissue, low grade and high grade PCa tissues are shown. (a) Analysis of 
immunostaining intensity. Under a 100× magnification, the stain intensity was graded as no stain, weak, moderate, and strong stain. (B) Subcellular localization 
is shown under a 400× magnification.
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that of HIF-1α, HURP, and VEGF: IHC signals were not present in 
benign prostatic epithelia and in low grade of PCa, and not present 
in nuclei of high grade PCa cells. However, staining was strong in 
cellular membrane and cytoplasm of high grade PCa.
Methylation of hUrP Promoter is 
associated with the Decrease of hUrP 
expression in Pca cell lines
Aberrant DNA methylation is a common epigenetic aberration 
in PCa and has led to the identification of markers for disease 
diagnosis and prognosis (33). To determine whether an epige-
netic mechanism contributes to the downregulation of HURP 
expression in PCa cells, DNA methylation status at the promoter 
region of the HURP gene was examined in the PCa cell lines 
LNCaP, DU-145, and PC3. Analysis of the methylation status 
of the promoter for two independent experiments in the cell 
lines revealed a significant increase of the methylation level of 
the promoter of HURP (cg 25465634-4010161) in LNCaP cells, 
when compared to the methylation level noted in DU-145 or PC3 
cell as shown in Figure 8A. Interestingly, the noted increase of 
the promoter methylation was associated with decrease of protein 
level of HURP (4.5, 1.1, and 0.5 relative density units for PC3, 
DU-145, and LNCaP, respectively) as evidenced by densitometry 
analysis of the Western blot signals (Figures 8B,C).
analysis of hUrP Promoter for  
hiF-1-Binding sites
To show whether the regulation of DLGAP5/HURP gene expres-
sion is HIF-1-dependent, we analyzed the putative HIF binding 
sites on the promoter of DLGAP5/HURP gene. The analysis of the 
non-translated region upstream from the start codon (9057 nt), 
using the 5′-rcgtg-3′ (R = g/a) motif identified by Wenger et al. 
(24), revealed four putative HIF binding sites, 5′-GCGTG-3′ at 
position: −8310; 5′-ACGTG-3′ at position: −3815; 5′-ACGTG-
3′ at position: −2616; and 5′-GCGTG-3′ at position: −1134 
upstream from the start codon (+1). The positions of the identified 
binding sites are outlined in Table 1. This information suggests an 
essential role for HIF-1 transcription factor in the transcriptional 
activation DLGAP5/HURP promoter in response to hypoxia.
DiscUssiOn
We investigated the effect of hypoxia on the expression of HURP 
in human PCa cells. In the C4-2B cell line hypoxia, as expected, 
modified cell viability and increased the rate of release and 
mRNA expression of VEGF, the pro-angiogenic factor. Likewise, 
mRNA expression of CA9, a marker for hypoxic exposure and 
tumor aggressiveness, was highly induced in response to low pO2. 
Both Western blot and mRNA expression analyses in LNCaP and 
C4-2B cells showed that HURP expression was reduced by time 
of culture in normoxia. Hypoxia, however, accelerated the rate of 
decrease of HURP expression. In contrast to what was observed 
in vitro, HURP expression was increased in PCa tumors, and its 
elevated expression seems to be associated with tumor grade. 
Overall, our studies suggest that tumor-associated hypoxia is a 
relevant determinant of the expression of HURP in PCa cells.
FigUre 8 | Methylation of hUrP promoter and hUrP expression in 
Pca cell lines. (a) Epigenetic analysis of the promoter of HURP 
demonstrated the methylation status in LNCaP, DU-145, and PC3 cells in 
two independent experiments per cell line. (B) Protein lysates (50 μg) 
extracted from whole cell lysates were separated by SDS-PAGE. Hepatoma 
upregulated protein (HURP) and glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) levels in the samples were identified by Western blot as described 
in Section “Materials and Methods.” GAPDH was used as internal control for 
loading and transfer. (c) The relative intensities of the bands were quantified 
using the ImageJ software, and all the values were normalized to the 
intensities of the respective GAPDH signal.
We and others have demonstrated the effects of low pO2 on 
viability responses in cultured PCa cells (28, 34–40). In agreement 
with our previous findings (28) the C4-2B subline, a derivative of 
the LNCaP cell line, grew slower in hypoxia than cells cultured 
under normoxia (Figure 1). The methodology for assessment of 
TaBle 1 | identified putative hiF-1-binding sites in the promoter 
sequence of the DLGAP5 gene.
Upstream position sequence (5′–3′)
8310–8306 GCGTG
3815–3811 ACGTG
2616–2612 ACGTG
1134–1130 GCGTG
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cell viability was validated by us in the initial phase of our study. 
We used different cell densities and various timelines including 
the one referred herein (8 days) or even longer time points. As 
expected, effects on cell numbers and VEGF production were 
proportional to cell densities. Although our studies have the 
limitation of the lack of information regarding the effect of oxy-
gen on cells of those with prostatic carcinoma origin, they add to 
the information indicating the effect of low pO2 on the viability 
responses in cultured PCa cells.
The adaptive response of PCa cells to a changing metabolism 
and survival environment has been considered a relevant factor 
of tumor aggressiveness. A component of the response of cancer 
cells to hypoxia is VEGF. Since hypoxia promotes secretion of 
this pro-angiogenic factor (30, 41, 42), assessment of its release 
to the culture medium can be used as an indicator of low pO2. 
C4-2B cells cultured under low pO2 showed increased VEGF 
release rate. The increase in VEGF secretion rate was tran-
scriptionally driven, as it could be expected (30, 41, 42). The 
hypoxia-inducible enzyme CA9, overexpressed in cancer cells 
(26), has been proposed as a marker for hypoxic exposure and 
tumor aggressiveness (27). Accordingly, we demonstrated that 
under hypoxic culture CA9 transcripts were elevated nearly 
by 200-fold in hypoxic C4-2B cells, when compared to cells 
growing under normoxic conditions. All together these results 
show that, in agreement to reported findings obtained in other 
cell lines (28, 43), the C4-2B subline shows characteristics of 
increased aggressiveness when cultured under hypoxia.
In a previous report, using a validated data mining approach 
(21, 44–46), we identified hypoxia-associated genes that can be 
utilized as markers of aggressive PCa (6). Among these genes, 
transcripts of HURP were associated with Gleason score and 
systemic progression. We further validated HURP as an inde-
pendent outcome predictor in high-risk PCa (6). Our published 
data supported the association of the hypoxic transcriptome 
and PCa, and provided evidence to sustain the participation of 
hypoxia-associated genes into the mechanisms of PCa progres-
sion. To further support this hypothesis, we scrutinized the pro-
moter region of HURP for binding sites of HIF-1α (Table 1). We 
found four putative HIF binding sites upstream of the HURP 
transcription start.
Most of the identified binding sites for HIF-1α on the pro-
moter of HURP reside in highly methylated regions, known 
to be commonly inversely correlated with gene expression and 
gene methylation in cancer cells (47), including PCa cell lines 
(48). In support of a notion for the regulatory effects of promoter 
methylation on HURP expression, we found that the increased 
methylation of HURP promoter (Figure 8A) is associated with 
a reduction in protein levels in the cell lines LNCaP, DU-145, 
and PC3 (Figure 8B). Epigenetic modification of the HURP pro-
moter, therefore, correlates with reduction of HURP expression. 
Although the data does not include hypoxia as an experimental 
variable, these findings suggest that the methylation of HURP 
promoter is responsible for the reduction of the basal expression 
of HURP in PCa cell lines. It may be anticipated that low oxygen, 
a condition known to increase tumor aggressiveness will have 
regulatory effects on HURP expression. Increased methylation 
of promoters can repress gene expression by directly preventing 
binding of transcription factors (49). It may be plausible to sug-
gest that methylation of HURP promoter may prevent the bind-
ing of HIF to its promoter region. As a consequence, inhibition of 
HURP expression may occur. This highly speculative hypothesis 
is interesting since it suggests a regulatory effect of methylation in 
silencing HURP gene expression in PCa cells exposed to hypoxia. 
Future studies are necessary to directly prove the importance 
of HIF-1α binding sites on HURP promoter, or that of other 
signaling factors associated with cellular responses to hypoxia, 
on the regulation of HURP expression under hypoxia condition. 
Utilization of epigenetic drug treatment of PCa cell lines followed 
by gene expression analysis for HURP may allow us to assess the 
effects of pO2 on the expression of HURP. Those experiments 
deserve special attention due to the reported effects that promoter 
methylation exerts on expression of hypoxia-controlled genes 
(e.g., CA9, studied herein) in context of tumor microenviron-
ment (23).
Analysis of protein levels of HIF-1α showed that expression 
of this transcription factor, essentially involved in the cellular 
response to hypoxia, was observed in PCa cells cultured under 
normoxia. Those findings are consistent with literature showing 
that HIF-1α is expressed in normoxic conditions as a means 
to carry out a regulatory role in response to regulatory factors 
such as cytokines, hormones, and genetic alterations (50, 51). 
Independent of the cell line, HIF-1α expression was maintained 
at a higher level under prolonged (8 days) hypoxia. Elevated and 
sustained HIF-1α expression via a non-transcriptional mecha-
nism has been demonstrated to block DNA replication (52). By 
binding to components of the pre-replicative complexes that 
assemble at origins of replication, HIF-1α inhibited the activa-
tion of minichromosome maintenance helicase, consequently 
hindering unwinding of the DNA during replication (52). It is 
likely, that the transcription-independent mechanism of cell cycle 
arrest in response to hypoxia may be operating in the studied PCa 
cell lines. Additional experiments are needed to clarify this point.
We analyzed protein expression of HURP in tumors and 
made associations with the expression of hypoxia-associated 
molecules. As a follow-up of our report showing increased 
transcripts of HURP in association with increase in the Gleason 
score and systemic progression (6), the level of HURP protein 
analyzed by Western blot (Figure 6) and IHC (Figures 7A,B) 
was higher in tumors relative to control tissue. These results 
agree with a previous study showing elevated expression of 
HURP protein in fine needle cell aspirates obtained from hepa-
tocellular carcinoma patients (53). In the cited study, further 
analysis revealed association between positive HURP staining 
and a shorter disease-free survival (53). In our case, analysis of 
larger number of samples will allow us to establish an associa-
tion between HURP expression and aggressive PCa. This study 
is certainly needed given the inter-individual heterogeneity in 
HURP expression noted by us in non-tumor tissue as well as in 
prostate carcinomas. We cannot provide explanation for those 
findings at this point. However, we suggest that histological 
observation is certainly a good complement to Western blot 
analysis. Histological techniques helped us to reveal with higher 
sensitivity distinct features for tissue expression of HURP not 
clearly revealed by Western blot analysis.
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Our results in PCa tumors, however, somehow, contra-
dict evidence in PCa cell line cultures showing that HURP 
expression was reduced as a function of incubation time and 
hypoxia. We attribute the apparent discordant results in part 
to the presence of complex interactions of the tumor micro-
environment observed in tumors (54). Equally relevant is the 
variability provided by the well-known heterogeneity in PCa 
(55). A reduction in HURP expression in relation with incuba-
tion time is expected based on the cell cycle-associated nature 
of this protein (13–15). We still do not have direct evidence 
experimental of the direct role of hypoxia in HURP’s expres-
sion and the status of other signaling pathways involved in its 
regulation. Despite of the lack of information, the literature 
has illustrated pathway-specific differences between tumor cell 
lines and tumor cells (56). Use of pathway-specific enrichment 
analysis of publicly accessible microarray data and quantified 
the gene expression differences between cell lines, tumor, and 
normal tissue cells for different tissue types including PCa, 
revealed substantive numbers of genes and associated pathways 
common between cell lines and tumor cells (56). In that study, 
however, a fraction of pathways showed expression profiles that 
differed significantly between cell lines and tumors included 
cell cycle and a number of metabolic and transcription-related 
pathways (56). Among them, metabolic pathways closely sen-
sitive to variation of the tumor microenvironment (e.g., ATP 
synthesis, oxidative phosphorylation, pyrimidine and purine 
metabolism, and proteasome) were significantly altered in cell 
lines compared to tumors (56). Over the basis of those results, 
we can postulate that characteristics of the tumor microenvi-
ronment, including presence of metabolites, cell-to-cell inter-
action in the multilayered structure of solid tumors, among 
many others may be particularly relevant for the expression 
of HURP in tumors. Differences in environmental selection 
pressure between in vitro culture and tumor tissue may help to 
explain, in part, our dissimilar results.
Hypoxia in tumor regions exists due to multiple factors, such 
as low blood irrigation, aberrant angiogenesis, and excessive 
oxygen consumption by cancer cells. The hypoxic areas are 
characterized by variable blood flow and pO2. In common with 
other solid tumors, pO2 in PCa fluctuates, resulting in acute and 
chronic hypoxia (3). Mostly because of the conflicting informa-
tion showing lack of correlation between pO2 values measured 
in the PCa nidus and clinical outcome (3), assessing pO2 in PCa 
tissue is at preliminary stages. A number of publications have 
indicated a correlation of hypoxia-associated molecules, such 
as VEGF, HIF-1α, osteopontin, lysil oxidase, and glucose trans-
porter-1 with pathology and patient features in PCa [reviewed 
in Stewart et  al. (3)]. Therefore, hypoxia-associated molecules 
are reliable as subrogates of hypoxia and indicators of aggres-
sive tumors. In agreement with this notion, tumor expression 
of HURP, along with expression of HIF-1α, VEGF (a HIF-1α 
target), and HSP60 (involved in the regulation of HIF-1α protein 
stability) were associated with PCa progression. It is therefore 
likely that the relationship between expression of HURP and 
hypoxia-responsive molecules that we observed in  vitro has 
a histological counterpart in PCa tumors. We postulate that 
localization of HURP protein in PCa tumors should be further 
explored as subrogate of tumor hypoxia and as marker of aggres-
sive disease.
cOnclUsiOn
The role of pO2 in PCa pathobiology has been underappreci-
ated. Tumor-associated hypoxia has been associated with 
malignant progression, metastasis, resistance to therapy, and 
poor clinical outcome. Among hypoxia-associated proteins, 
HURP has multifunctional biological properties, which are 
compatible with its role in carcinogenesis. A direct cause 
and effect relationship between hypoxia and HURP expres-
sion is yet to be established. Nevertheless, our findings bring 
insight into the effect of low oxygen on expression of HURP 
in PCa. Additionally our results provide basis for utilization 
of tumor-associated molecules as relevant tumor markers. The 
expression of HURP, together with that of hypoxia-responsive 
molecules, such as HIF-1α, VEGF, and HSP60, may serve as 
predictor of aggressive tumors.
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